Abstract
BoNT/A seems to be a promising alternative in the treatment of BPH-related LUTS with a good tolerance and safety profile. However, the level of evidence is still low and further randomized controlled studies are mandatory.
Chartier-Kastler, E; Mehnert, Ulrich; Denys, P; Giuliano, F (2011). Botulinum neurotoxin A for male lower urinary tract symptoms. Current Opinion in Urology, 21(1):13-21.
Abstract
BoNT/A seems to be a promising alternative in the treatment of BPH-related LUTS with a good tolerance and safety profile. However, the level of evidence is still low and further randomized controlled studies are mandatory.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Balgrist University Hospital, Swiss Spinal Cord Injury Center |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Urology |
| Language: | English |
| Date: | 2011 |
| Deposited On: | 04 Jan 2012 15:09 |
| Last Modified: | 23 Jan 2022 20:03 |
| Publisher: | Lippincott Wiliams & Wilkins |
| ISSN: | 0963-0643 |
| OA Status: | Green |
| Publisher DOI: | https://doi.org/10.1097/MOU.0b013e3283410117 |
| PubMed ID: | 21099691 |
Chartier-Kastler, E